Related Experiment Videos
Changes in serotonin, but not catecholamine, receptor binding in the brain of morphine-dependent rats
Molecular Pharmacology
|September 1, 1981
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Are the school prevention programmes - aimed at de-normalizing smoking among youths - beneficial in the long term? An example from the Smoke Free Class Competition in Italy.
Annali di igiene : medicina preventiva e di comunita·2017
Developmental effects of early postnatal treatment of rats with prochlorperazine.
International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience·2014
Evidence of the existence of two different intraneuronal pools from which pharmacological agents can release serotonin.
Neurochemistry international·2010
Effects of m-chlorophenylpiperazine on receptor binding and brain metabolism of monoamines in rats.
Neurochemistry international·2009
Roles of the phosphorylation sites of distinct α1A-adrenergic receptor domains.
Molecular pharmacology·2026
A-kinase anchoring protein complexes and cAMP signaling within the dorsal root ganglia in chronic pain.
Molecular pharmacology·2026
Anchored kinase and phosphatase signaling networks in amyloid β-induced synaptic dysfunction.
Molecular pharmacology·2026
Where are peptide ligands of potassium channels sourced from?
Molecular pharmacology·2026
Regulation of organic anion transporting polypeptide 1B1 transport function by lysine deacetylase 6.
Molecular pharmacology·2026
Buprenorphine Dispensed by Pharmacies and Administered in Emergency Departments in Urban and Rural Areas - United States, 2019-2025.
MMWR. Morbidity and mortality weekly report·2026
Rheumatoid Arthritis Guidelines Require Dietary Recommendations: An Overlooked Opportunity.
Clinical nutrition ESPEN·2026
Assessment of the impact of valproic acid co-administration on clozapine plasma concentrations in Tunisian patients.
Drug metabolism and personalized therapy·2026
Benefit-Risk of Voxelotor, Crizanlizumab, and L-Glutamine in Sickle Cell Disease: A Systematic Review.
The American journal of the medical sciences·2026